KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Shares Outstanding (2016 - 2025)

Moderna (MRNA) has disclosed Shares Outstanding for 6 consecutive years, with $385.0 million as the latest value for Q4 2022.

  • On a quarterly basis, Shares Outstanding fell 4.47% to $385.0 million in Q4 2022 year-over-year; TTM through Dec 2022 was $385.0 million, a 4.47% decrease, with the full-year FY2022 number at $385.0 million, down 4.47% from a year prior.
  • Shares Outstanding was $385.0 million for Q4 2022 at Moderna, down from $392.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $504.4 million in Q1 2018 to a low of $66.2 million in Q2 2018.
  • A 5-year average of $349.5 million and a median of $392.0 million in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: surged 404.55% in 2018, then crashed 35.22% in 2019.
  • Moderna's Shares Outstanding stood at $329.0 million in 2018, then rose by 2.43% to $337.0 million in 2019, then rose by 18.4% to $399.0 million in 2020, then rose by 1.0% to $403.0 million in 2021, then decreased by 4.47% to $385.0 million in 2022.
  • Per Business Quant, the three most recent readings for MRNA's Shares Outstanding are $385.0 million (Q4 2022), $392.0 million (Q2 2022), and $400.0 million (Q1 2022).